Genetically-modified Autologous T Cells
- Name
- Genetically-modified Autologous T Cells
- Accession Number
- DBCAT005469
- Description
Not Available
- Drugs
Drug Drug Description Tisagenlecleucel A CAR T cell therapy for relapsed or refractory large B-cell lymphoma and diffuse large B-cell lymphoma. Axicabtagene ciloleucel A CAR T-cell therapy used to treat adults with large B-cell lymphomas and follicular lymphoma. - Drugs & Drug Targets
Drug Target Type Tisagenlecleucel B-lymphocyte antigen CD19 target Axicabtagene ciloleucel B-lymphocyte antigen CD19 target